Advanced Microbiome Interventions

Advanced Microbiome Interventions (AMI) is a biotechnology company focused on developing novel microbial therapies to treat diseases associated with gut microbiome dysbiosis. The company leverages its expertise in microbiology and clinical medicine to create standardized, safe, and effective live biotherapeutic products. Their primary focus is on addressing recurrent Clostridioides difficile infections and chronic inflammatory bowel diseases. By utilizing defined microbial consortia, AMI aims to provide a more controlled and scalable alternative to traditional fecal microbiota transplants. The company is currently advancing its lead candidates through pre-clinical development to establish a robust pipeline of microbiome-targeted interventions.